Pay in 4 interest-free payments of $7.22 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Breakthrough of the Year: Obesity meets it match
This page draws from regulatory sources, clinical-trial registries, peer-reviewed studies, PubMed-indexed literature, and scientific databases
Dosing & Reconstitution Guide AHK-Cu has no weight-based dose, no titration ladder and no validated injectable dose at all there is no human trial to anchor to [1]
The growth hormone fragment that targets fat metabolism, in a no-needle daily form
Noteworthy, lower efficacy of obesity management medications in patients with T2D is a well-documented and established finding
Kenzheshova A et al
US$ 29.59
US$ 21.00
US$ 23.56
